These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 1362370

  • 1. Clozapine rechallenge after an episode of 'neuroleptic malignant syndrome'.
    Weller M, Kornhuber J.
    Br J Psychiatry; 1992 Dec; 161():855-6. PubMed ID: 1362370
    [Abstract] [Full Text] [Related]

  • 2. [Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?].
    Weller M, Kornhuber J.
    Fortschr Neurol Psychiatr; 1993 Jun; 61(6):217-22. PubMed ID: 8330832
    [Abstract] [Full Text] [Related]

  • 3. Neuroleptic malignant syndrome associated with clozapine treatment.
    Tsai G, Crisostomo G, Rosenblatt ML, Stern TA.
    Ann Clin Psychiatry; 1995 Jun; 7(2):91-5. PubMed ID: 8556099
    [Abstract] [Full Text] [Related]

  • 4. Clozapine Rechallenge Following Neuroleptic Malignant Syndrome: A Systematic Review.
    Lally J, McCaffrey C, OʼMurchu C, Krivoy A, Guerandel A, MacCabe JH, Gaughran F.
    J Clin Psychopharmacol; 2019 Jun; 39(4):372-379. PubMed ID: 31205196
    [Abstract] [Full Text] [Related]

  • 5. Rechallenging clozapine after neuroleptic malignant syndrome.
    Anbalagan E, Ithman M, Lauriello J.
    Psychiatr Q; 2014 Sep; 85(3):345-8. PubMed ID: 24633526
    [Abstract] [Full Text] [Related]

  • 6. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS.
    Illing M, Ancill R.
    Can J Psychiatry; 1996 May; 41(4):258. PubMed ID: 8726793
    [No Abstract] [Full Text] [Related]

  • 7. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T, Tzavellas E, Ferentinos P, Mourikis I, Liappas J.
    World J Biol Psychiatry; 2009 May; 10(1):70-3. PubMed ID: 19673089
    [Abstract] [Full Text] [Related]

  • 8. Neuroleptic rechallenge after neuroleptic malignant syndrome.
    Giacardi-Paty M, Bottai T, Pujalte D, Lainey E, Petit P.
    Br J Psychiatry; 1993 Jul; 163():121-2. PubMed ID: 8102585
    [No Abstract] [Full Text] [Related]

  • 9. Neuroleptic malignant syndrome and clozapine.
    Reddig S, Minnema AM, Tandon R.
    Ann Clin Psychiatry; 1993 Mar; 5(1):25-7. PubMed ID: 8102300
    [Abstract] [Full Text] [Related]

  • 10. Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis: a case report.
    Gönner F, Baumgartner R, Schüpbach D, Merlo MC.
    Psychopharmacology (Berl); 1999 Jun; 144(4):416-8. PubMed ID: 10435416
    [Abstract] [Full Text] [Related]

  • 11. Clozapine-induced neuroleptic malignant syndrome in an adolescent.
    Matheson KM, Gray G.
    J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):322-4. PubMed ID: 22897669
    [No Abstract] [Full Text] [Related]

  • 12. Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge.
    Huang TL.
    Chang Gung Med J; 2001 Aug; 24(8):522-5. PubMed ID: 11601195
    [Abstract] [Full Text] [Related]

  • 13. Successful use of clozapine in a patient with a history of neuroleptic malignant syndrome.
    Stoudemire A, Clayton L.
    J Neuropsychiatry Clin Neurosci; 1989 Aug; 1(3):303-5. PubMed ID: 2577714
    [Abstract] [Full Text] [Related]

  • 14. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
    Franzen D, Burkhard J, Corti N, Schüpbach D, Fontanel D, Stäubli M.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
    [Abstract] [Full Text] [Related]

  • 15. Neuroleptic malignant syndrome: a preventive program.
    Fernando ML, Manchanda R, Kirk C.
    J Psychiatry Neurosci; 1992 Mar; 17(1):31-3. PubMed ID: 1349827
    [Abstract] [Full Text] [Related]

  • 16. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.
    Tseng PT, Chang YC, Chang CH, Wang HY, Cheng YS, Wu CK, Chen YW, Chung W.
    Int J Psychiatry Med; 2015 Mar; 49(1):35-43. PubMed ID: 25838319
    [Abstract] [Full Text] [Related]

  • 17. Clozapine treatment and neuroleptic malignant syndrome.
    Doan RJ, Callaghan WD.
    Can J Psychiatry; 2000 May; 45(4):394-5. PubMed ID: 10813077
    [No Abstract] [Full Text] [Related]

  • 18. A case of clozapine-induced neuroleptic malignant syndrome.
    Miller DD, Sharafuddin MJ, Kathol RG.
    J Clin Psychiatry; 1991 Mar; 52(3):99-101. PubMed ID: 1672311
    [Abstract] [Full Text] [Related]

  • 19. Neuroleptic malignant syndrome and clozapine monotherapy.
    Chatterton R, Cardy S, Schramm TM.
    Aust N Z J Psychiatry; 1996 Oct; 30(5):692-3. PubMed ID: 8902179
    [Abstract] [Full Text] [Related]

  • 20. Clozapine-induced neuroleptic malignant syndrome: review and report of new cases.
    Sachdev P, Kruk J, Kneebone M, Kissane D.
    J Clin Psychopharmacol; 1995 Oct; 15(5):365-71. PubMed ID: 8830069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.